Evidence map›Paper›PMID 19571109›Full record

ArticleClinical and vaccine immunology : CVI2009

An oral Mycobacterium bovis BCG vaccine for wildlife produced in the absence of animal-derived reagents.

Martin L Cross, Matthew R Lambeth, Frank E Aldwell

Abstract read
In one paragraph

Article in Clinical and vaccine immunology : CVI, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Review
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Martin L CrossCentre for Innovation, University of Otago, P.O. Box 56, Dunedin, New Zealand. frank.cross@otago.ac.nz
Matthew R Lambeth
Frank E Aldwell

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Cultures of Mycobacterium bovis BCG, comprising predominantly single-cell bacilli, were prepared in broth without animal-derived reagents. When formulated into a vegetable-derived lipid matrix, the vaccine was stable in vitro and was immunogenic in vivo upon feeding it to mice. This formulation could be useful for oral vaccination of wildlife against tuberculosis, where concern over transmissible prions may preclude the field use of vaccines containing animal products.

Indexed as

Adjuvants, ImmunologicAdministration, OralAnimalsBCG VaccineCulture MediaDrug StabilityFemaleInterferon-gammaLeukocytes, MononuclearLipidsMiceMice, Inbred BALB CMycobacterium bovisSpleenTechnology, PharmaceuticalAdjuvants, ImmunologicBCG VaccineCulture MediaInterferon-gammaLipids

Identifiers

PMID19571109
PMCPMC2745018

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.